Prevalence of SARS-CoV-2 Antibody in 2,935 Healthcare Workers at 6 Major Hospitals, Daegu, Korea대구 6대병원 의료진 2,935명의 SARS-CoV-2 항체 유병률Article Published on 2021-11-082022-09-12 Journal: Journal of Korean medical science [Category] MERS, SARS, 진단, [키워드] Abbott acute respiratory syndrome antibody Antibody test blood specimen collected Community coronavirus disease Coronavirus-2 COVID-19 criteria detection diagnosed with COVID-19 Elecsy electrochemiluminescence immunoassay enzyme-linked immunosorbent Genscript HCW HCWs healthcare worker hospital IgG Inc. Major much lower neutralizing antibody occurred outbreak park performed positive positive rate Prevalence Roche Diagnostics SARS-CoV-2 SARS-CoV-2 antibody screening test screening tests specimen subject subjects Switzerland the SARS-CoV-2 USA was determined was performed was tested worker [DOI] 10.3346/jkms.2021.36.e294 PMC 바로가기 [Article Type] Article
Humoral Response after Vaccination with Half-Dose of BNT162b2 in Subjects under 55 Years of AgeArticle Published on 2021-11-042022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] antibody level comparable Coverage COVID-19 COVID-19 pandemic Detection limit dose Elecsy help humoral mRNA vaccine of BNT162b2 participant Participants proportion response Roche Diagnostics SARS-CoV-2 statistically significant the vaccine vaccination were measured widespread Year [DOI] 10.3390/vaccines9111277 PMC 바로가기 [Article Type] Article
SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala과테말라에있는 대량 안과 센터에서 의료 종사자의 SARS-Cov-2 SeroprevalenceResearch Article Published on 2021-11-022022-09-01 Journal: Annals of Medicine [Category] SARS, 바이오마커, 진단, [키워드] 95% CI age anti-SARS-CoV-2 antibodies antibodies antibody collected community transmission comparable conducted COVID-19 cross demographic characteristics determine Elecsy Factor females FIVE Gender groups HCW healthcare healthcare worker Healthcare workers high risk higher risk immunoassay Infection Logistic regression majority Nurses ophthalmology Patient positive Prevalence Probability reactive reported Result risk Roche SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 seroprevalence Seropositivity Seroprevalence serum sample serum samples tested total antibodies total antibody was used were given [DOI] 10.1080/07853890.2021.1993325 PMC 바로가기 [Article Type] Research Article
Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassayRoche Elecsys Anti-SARS-CoV-2 S 면역분석의 성능 평가Article Published on 2021-11-012022-09-11 Journal: Journal of virological methods [Category] MERS, SARS, 진단, 치료기술, 치료법, [키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 anti-S antibodies antibody Architect assays Centaur coronavirus demonstrated Elecsy Elecsys Elecsys® Anti-SARS-CoV-2 S Euroimmun evaluated Germany iFlash IgA IgG IgM immunoassay nucleocapsid protein Patient PCR-confirmed performance Population Protein respiratory Roche Roche Diagnostics S1/S2 SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 PCR sensitivity Sensitivity analyses Seven severe acute respiratory syndrome Coronavirus significantly higher specificity spike Spike protein Switzerland tested Total [DOI] 10.1016/j.jviromet.2021.114271 PMC 바로가기 [Article Type] Article
Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communities에티오피아에서 SARS-CoV-2의 혈청 역학 및 모델 기반 예측: 최전선 병원 직원 및 지역사회를 대상으로 한 종단 코호트 연구Article Published on 2021-11-012022-09-11 Journal: The Lancet. Global health [Category] Fulltext, MERS, 치료법, [키워드] 95% CI anti-SARS-CoV-2 Arts blood sample Blood samples cohorts Community convenience sampling COVID-19 credible interval CrI Deutsche Forschungsgemeinschaft disease education Elecsy Elecsys eligible estimate Germany health-care Horizon hospital hospitals household incidence incidence rate incidence rates increase in longitudinal cohort study Older over participant provided recruited reported SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 seroprevalence Seroepidemiology serology Seroprevalence Spread state study period Surveillance town venepuncture was done written Informed Consent [DOI] 10.1016/S2214-109X(21)00386-7 PMC 바로가기 [Article Type] Article
Evaluation of the Elecsys SARS-CoV-2 antigen assay for the detection of SARS-CoV-2 in nasopharyngeal swabs비인두 면봉에서 SARS-CoV-2 검출을 위한 Elecsys SARS-CoV-2 항원 분석 평가Article Published on 2021-11-012022-09-11 Journal: Journal of Clinical Virology [Category] SARS, 치료기술, [키워드] 95% CI Accuracy Antigen antigenic assays automated Automated antigen immunoassay collected confirmation COVID-19 cut-off cut-off value diagnosed Elecsy Elecsys evaluate gold gold standard highest Nasopharyngeal swab nasopharyngeal swabs performed positive Randomly reached relative sensitivity reported RT-PCR SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 detection SARS-COV-2 infection SARS-CoV-2 testing SARS-CoV-2 testing strategy screening strategy sensitivity specificity tested [DOI] 10.1016/j.jcv.2021.104991 PMC 바로가기 [Article Type] Article
Neutralizing antibody responses following natural SARS-CoV-2 infection: Dynamics and correlation with commercial serologic tests자연적인 SARS-CoV-2 감염에 따른 중화 항체 반응: 상업적 혈청학적 검사와의 역학 및 상관관계Article Published on 2021-11-012022-09-11 Journal: Journal of Clinical Virology [Category] MERS, SARS, 진단, 치료기술, 치료법, [키워드] allocation anti-SARS-CoV-2 Anti-spike Antibody Response Antibody titer Antibody titers assays booster doses correlation COVID-19 cross-reactivity demonstrated detect diagnostic domain Dynamics Efficacy Elecsy Elecsys ELISA Euroimmun evaluate evaluated except for facilitate Follow-up healthcare worker IgG immunoassay immunoassays long term MONITOR NAbs Neutralizing antibodies Neutralizing antibody response neutralizing capacity participant participated performed plaque reduction neutralization Post-vaccine Protein reference standard SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 immunity SARS-COV-2 infection SARS-CoV-2 neutralizing antibodies sera serologic test serologic tests seronegative seroprevalence survey significant decrease Support the immunoassay total antibodies vaccination [DOI] 10.1016/j.jcv.2021.104988 PMC 바로가기 [Article Type] Article
Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 20212021년 6월 1일부터 7월 7일까지 스위스 제네바에서 실시된 백신 접종 캠페인 6개월 후 항-SARS-CoV-2 항체의 혈청 유행성Research Published on 2021-10-282022-09-10 Journal: Eurosurveillance [Category] MERS, SARS, 변종, 진단, 치료법, [키워드] age anti-N antibodies anti-S anti-S antibody anti-SARS-CoV-2 anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibodies antibody children conducted COVID-19 pandemic credible interval Critical cross-sectional delta variant effort Elecsy estimate General population groups highest immune immunoassays individual Infection lowest MOST nucleocapsid Older Older adults participant population-based Protein public health random random samples Result Roche SARS-CoV-2 delta Seroprevalence Serosurvey Spread Switzerland tested the SARS-CoV-2 vaccination vaccination rate vaccination rates Vaccine hesitancy [DOI] 10.2807/1560-7917.ES.2021.26.43.2100830 PMC 바로가기 [Article Type] Research
Use of Quantitative Dried Blood Spots to Evaluate the Post-Vaccination Level of Neutralizing Antibodies against SARS-CoV-2Article Published on 2021-10-222022-10-29 Journal: International Review of Cell and Molecular Biology [Category] COVID-19, [키워드] anti-S anti-S antibody Anti-SARS-CoV-2 S antibodies antibody Blood blood sample carried Clinical studies Cohort Combination composed COVID-19 infection COVID-19 pandemic determine dose Elecsy first vaccination Frequency had no Immune status immunoassay Immunoglobulin individuals information investigated Level limit neutralizing antibodies detection neutralizing antibody Patient peaked persistence Pfizer plasma Population populations produced progression PROTECT Protein Quantitative quantitative dried blood spots random Roche SARS-CoV-2 second dose serum/plasma spot stimulated subject subjects vaccination vaccination against SARS-CoV-2 Vaccine venous viral spike Volunteer [DOI] 10.3390/life11111125 PMC 바로가기 [Article Type] Article
Prevalence of COVID-19 among blood donors: The Jordan University of Science and Technology experienceObservational Study Published on 2021-10-152022-10-05 Journal: Medicine [Category] SARS, 임상, [키워드] acute respiratory syndrome affected antibody antibody status Blood blood donor Blood Group caused Community coronavirus COVID-19 COVID-19 antibody COVID-19 infection determine Donor Elecsy Health healthy IgG antibody Immunity Infection Jordan knowledge less Local males median age pandemic participant positive Prevalence prevalence of COVID-19 Prospective Study SARS-CoV-2 Science seropositive smoker technology tertiary referral hospital tested university virus [DOI] 10.1097/MD.0000000000027537 PMC 바로가기 [Article Type] Observational Study